RecruitingNCT06927102

From Exclusion to Inclusion: Analysing Follow-up Discontinuity in Breast Cancer

A Comprehensive Analysis of Follow-up Outcomes, Continuity and Updated Survivorship in Breast Cancer

Sponsor

Basavatarakam Indo American Cancer Hospital & Research Institute

Enrollment

1,500 participants

Start Date

May 1, 2025

Study Type

OBSERVATIONAL

Conditions

Breast Carcinoma

Summary

The goal of this observational study is to determine the proportion of patients who are lost-to-follow-up at five years, identify factors associated with loss of follow-up , and explore patient-reported barriers to follow-up in a public sector cancer care setting. The main question it aims to answer is : Do proactive outreach programs help in improving follow-up rates among breast cancer patients who are categorized as "lost-to-follow-up." This study will be conducted in a real-world cohort of women with non-metastatic breast cancer treated at a tertiary care centre, between 2017-2018.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating why some breast cancer patients do not continue attending follow-up appointments after their initial diagnosis and treatment. It aims to re-engage patients who were "lost to follow-up" and understand the barriers they faced, in order to improve future cancer care for all patients. **You may be eligible if...** - You were newly diagnosed with non-metastatic breast cancer between 2017 and 2018 - You missed follow-up appointments and were classified as "lost to follow-up" - You are willing to participate after being re-contacted **You may NOT be eligible if...** - Your medical records are incomplete - You received part of your treatment at a different hospital outside the study centre - You have permanently relocated out of the study region Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

Basavatarakam Indo American Cancer Hospital & Research Institute

Hyderabad, Telangana, India

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06927102

Related Trials

Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial

NCT0618475011 locations

The Vanguard Study: Testing a New Way to Screen for Cancer

NCT0699589837 locations

A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)

NCT070671381 location

Neutrophil Extracellular Traps Formation in Breast Cancer Patients Taking Tamoxifen

NCT050568571 location

Endocrine Therapy-Induced Alopecia in Postmenopausal and Premenopausal Female Breast Cancer Patients

NCT0561210023 locations